Abstract
We measured antifungal activity against 128 cryptococcal isolates (86 of C. neoformans and 42 of C. gattii) to determine if differences in serotype susceptibility exist. Contrary to previous results, we found no serotype susceptibility differences. Isavuconazole, posaconazole, and voriconazole demonstrated excellent potency against each isolate and serotype, including isolates with reduced fluconazole susceptibilities.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 309-311 |
| Number of pages | 3 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 53 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2009 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS